Por favor, use este identificador para citar o enlazar este ítem:
https://www.arca.fiocruz.br/handle/icict/16612
Tipo
ArtículoDerechos de autor
Acceso abierto
Colecciones
- IOC - Artigos de Periódicos [12502]
Metadatos
Mostrar el registro completo del ítem
USING SEROPREVALENCE AND IMMUNISATION COVERAGE DATA TO ESTIMATE THE GLOBAL BURDENOF CONGENITAL RUBELLA SYNDROME, 1996-2010:A SYSTEMATIC REVIEW
Vacinação de rubéola
Dados de seroprevalência
Imunização
rubella vaccination
Seroprevalence data
immunization
Autor
Afiliación
Public Health England. London, United Kingdom / London School of Hygiene & Tropical Medicine. London, United Kingdom.
Public Health England. London, United Kingdom / Aquarius Population Health. London, United Kingdom / University of Bristol, School of Social and Community Medicine. Bristol, United Kingdom.
London School of Hygiene &Tropical Medicine. London, United Kingdom.
Centers for Disease Control and Prevention. Atlanta,GA, USA.
Duke University Medical Center. Durham, NC, USA / Johns Hopkins Bloomberg School of Public Health. Baltimore, MD, USA.
World Health Organization. Geneva, Switzerland.
Nagasaki University. Institute of tropical Medicine. Nagasaki, Japan.
Public Health England. London, United Kingdom / Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Vírus respiratório e Sarampo. Rio de Janeiro, RJ, Brasil
London School of Hygiene &Tropical Medicine. London, United Kingdom / University College London. London, United Kingdom.
World Health Organization. Geneva, Switzerland.
World Health Organization. Geneva, Switzerland.
Public Health England. London, United Kingdom / Aquarius Population Health. London, United Kingdom / University of Bristol, School of Social and Community Medicine. Bristol, United Kingdom.
London School of Hygiene &Tropical Medicine. London, United Kingdom.
Centers for Disease Control and Prevention. Atlanta,GA, USA.
Duke University Medical Center. Durham, NC, USA / Johns Hopkins Bloomberg School of Public Health. Baltimore, MD, USA.
World Health Organization. Geneva, Switzerland.
Nagasaki University. Institute of tropical Medicine. Nagasaki, Japan.
Public Health England. London, United Kingdom / Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Vírus respiratório e Sarampo. Rio de Janeiro, RJ, Brasil
London School of Hygiene &Tropical Medicine. London, United Kingdom / University College London. London, United Kingdom.
World Health Organization. Geneva, Switzerland.
World Health Organization. Geneva, Switzerland.
Resumen en ingles
Background
The burden of Congenital Rubella Syndrome (CRS) is typically underestimated in routine surveillance. Updated estimates are needed following the recent WHO position paper on rubella and recent GAVI initiatives, funding rubella vaccination in eligible countries. Previous estimates considered the year 1996 and only 78 (developing) countries.
Palabras clave en portugues
Síndrome da rubéola congênitaVacinação de rubéola
Dados de seroprevalência
Imunização
Palabras clave en ingles
Congenital Rubella Syndromerubella vaccination
Seroprevalence data
immunization
Compartir